
Why Meta Offered Rs 10,400 Crore To This AI Genius And Still Got A 'No'
The tech firm founder rose to fame in 2023 after criticising Elon Musk, who then offered him a job. His latest revelation shows the sky-high offers top AI talent is receiving today
Daniel Francis, an AI expert and founder of the US-based tech firm Abel, has sparked a social media frenzy after revealing he turned down a jaw-dropping Rs 10,400 crore job offer from Meta. The four-year offer from the tech giant has raised eyebrows across the industry, leaving many wondering what made Meta so keen, and why Francis walked away.
The reason for Meta's interest in Daniel has now been revealed. On social media, he wrote, 'Friends! I was offered a salary of Rs 10,400 crore for four years. Even I have never seen this height before. What is going on?" In another post, he added, 'I want to tell you that I have turned down that job offer."
Daniel's AI Tech Stands Apart
Daniel possesses a unique AI technology, which Meta was keen to acquire to ensure it didn't fall into the hands of competitors. His technology includes algorithms that generate police reports from body cam footage and send call data automatically.
Daniel first gained prominence in 2023 when he publicly voiced his displeasure towards Elon Musk, who surprisingly offered him a job in one of his companies. His recent revelation highlights the immense offers AI talent is now attracting.
Meta is actively recruiting top technical staff, with OpenAI CEO Sam Altman stating last month that Meta plans to spend $100 million on hiring. Despite such large offers, no experts from other companies have joined Meta yet.
Meta's goal is to acquire all innovations in the technical field and build a 'Superintelligence Lab', offering substantial packages to AI experts.
view comments
First Published:
July 25, 2025, 17:02 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
23 minutes ago
- Mint
Small-cap pharma stock edges higher despite stock market sell-off; here's why
Stock Market Today: Small-cap pharma stock edged higher during the intraday trades on Thursday despite the stock market sell-off. Check details about Fredun Pharmaceuticals Q1 results. Fredun Pharmaceuticals Limited, a pharmaceutical formulation manufacturing company in India, reported its Q1 performance on Thursday, 31 July 2025. The Fredun Pharmaceuticals reported net profit at ₹ 6.77 Crore during the quarter ending June 2025, which was 63.82% higher compared to ₹ 4.13 crore in the year-ago quarter. As per its disclosed unaudited financials for the first quarter of fiscal year 26, the revenues at ₹ 119.86 crore grew 52.08% compared to ₹ 78.81 crore in the year-ago quarter. The boost to the bottom line was further provided by the improved operating performance. The Earnings before interest, tax, depreciation, and amortization, or EBITDA, at ₹ 16.99 crore grew 62.15% over ₹ 10.48 crore in the year-ago quarter Fredun Medhora, Managing Director, in a statement said that We are pleased to report a strong start to FY26 with a significant year-on-year growth in net profit and healthy improvement across all key financial metrics." The performance as per Medhora reflects the successful execution of our growth strategy and the continued demand for the company's diversified portfolio across domestic and international markets. The company's generics portfolio continues to strengthen, with over 1,200 products currently under registration. The current order book stands at over ₹ 200 crore, providing strong revenue visibility and momentum for the upcoming quarters. The company is diversified into generics, cosmetics, nutraceuticals, mobility, and animal healthcare products too. Fredun Pharmaceuticals share price opened at ₹ 1017.00 and gained further to RS 1020 levels on Thursday , marking intraday gains of 4.73% compared to previous day's closing price of ₹ 973.95 for the Fredun Pharmaceuticals share price The gains for the small-cap stock Fredun Pharmaceuticals share price were despite weak Indian stock markets on a day when Sensex corrected mor than 1% during intraday trades amid stock market sell-off. Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.


Deccan Herald
23 minutes ago
- Deccan Herald
Brigade Hotel Ventures shares drop nearly 10 pc in market debut trade
New Delhi, Shares of Brigade Hotel Ventures Ltd on Thursday listed with a discount of nearly 10 per cent against the issue price of Rs stock began trading at Rs 82, down 8.88 per cent from the issue price on the the NSE, it started trading at Rs 81.10, a discount of 9.88 per company's market valuation stood at Rs 3,279.94 initial share sale of Brigade Hotel Ventures Ltd fetched 4.48 times subscription on the closing day of bidding on initial public offering (IPO) had a price band of Rs 85-90 per Hotel Ventures' IPO was entirely a fresh issue of equity shares worth Rs 759.6 crore with no offer-for-sale (OFS) from the issue to the tune of Rs 468.14 crore will be used for the payment of debt, Rs 107.52 crore will be utilised for the purchase of an undivided share of land from the promoter, BEL, and the remaining funds will support acquisitions, other strategic initiatives, and general corporate Hotel Ventures Ltd is a subsidiary of Bengaluru-based real estate company Brigade Enterprises Ltd (BEL)..BEL entered into the hospitality business in 2004 with the development of its first hotel, Grand Mercure Bangalore, which commenced operations in company has a portfolio of nine operating hotels across Bengaluru, Chennai, Kochi, Mysuru, and the GIFT City (Gujarat) with 1,604 hotels are operated by global marquee hospitality companies such as Marriott, Accor and InterContinental Hotels Group.


Deccan Herald
23 minutes ago
- Deccan Herald
Pak PM Sharif calls trade deal with US 'historic', thanks Trump
I wish to convey my profound thanks to President Trump @realDonaldTrump for his leadership role in finalization of the historic US-Pakistan trade agreement, successfully concluded by our two sides in Washington, last night. This landmark deal will enhance our growing cooperation…